Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,836 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Fujitani K, Shitara K, Takashima A, Koeda K, Hara H, Nakayama N, Hironaka S, Nishikawa K, Kimura Y, Amagai K, Hosaka H, Komatsu Y, Shimada K, Kawabata R, Ohdan H, Kodera Y, Nakamura M, Nakajima TE, Miyata Y, Moriwaki T, Kusumoto T, Nishikawa K, Ogata K, Shimura M, Morita S, Koizumi W. Fujitani K, et al. Among authors: kimura y. Gastric Cancer. 2021 Mar;24(2):467-476. doi: 10.1007/s10120-020-01131-y. Epub 2020 Nov 2. Gastric Cancer. 2021. PMID: 33136231 Free PMC article. Clinical Trial.
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Takiuchi H, Goto M, Imamura H, Furukawa H, Imano M, Imamoto H, Kimura Y, Ishida H, Fujitani K, Narahara H, Shimokawa T. Takiuchi H, et al. Among authors: kimura y. Jpn J Clin Oncol. 2008 Mar;38(3):176-81. doi: 10.1093/jjco/hyn003. Epub 2008 Feb 16. Jpn J Clin Oncol. 2008. PMID: 18281707 Clinical Trial.
Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301).
Komatsu Y, Takahashi Y, Kimura Y, Oda H, Tajima Y, Tamura S, Sakurai J, Wakasugi T, Tatebe S, Takahashi M, Sakata Y, Kitajima M, Sakamoto J, Saji S. Komatsu Y, et al. Among authors: kimura y. Anticancer Drugs. 2011 Jul;22(6):576-83. doi: 10.1097/CAD.0b013e328345b509. Anticancer Drugs. 2011. PMID: 21512394 Free article. Clinical Trial.
Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.
Tamura S, Fujitani K, Kimura Y, Tsuji T, Matsuyama J, Iijima S, Imamura H, Inoue K, Kobayashi K, Kurokawa Y, Furukawa H; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Tamura S, et al. Among authors: kimura y. Oncology. 2011;80(5-6):296-300. doi: 10.1159/000329090. Epub 2011 Jul 18. Oncology. 2011. PMID: 21778769 Clinical Trial.
A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT.
Takiguchi S, Yamamoto K, Hirao M, Imamura H, Fujita J, Yano M, Kobayashi K, Kimura Y, Kurokawa Y, Mori M, Doki Y; Osaka University Clinical Research Group for Gastroenterological Study. Takiguchi S, et al. Among authors: kimura y. Gastric Cancer. 2012 Apr;15(2):198-205. doi: 10.1007/s10120-011-0098-1. Epub 2011 Oct 13. Gastric Cancer. 2012. PMID: 21993852 Clinical Trial.
5,836 results